Fertility and family-building benefits provider Kindbody is acquiring Phosphorus Labs, a preventative genomics company. The acquisition and addition of Phosphorus’s state-of-the-art reference laboratory will bring Kindbody’s genetic testing and screening in-house to deliver a seamless continuum of patient care. The Phosphorus team of critical intellectual capital geneticists and lab technicians will join Kindbody as its new KindLabs division. Just a few months…
According to AlleyWatch, hormone health company Aavia has raised an additional $3.7M in funding, which brings the total capital raised to $10.1M according to Crunchbase. The company is known for its signature birth control case, which reminds womxn to take their birth control pills on time. Aavia was founded in 2017 by Aagya Mathur, Alexis Wong, and Aya Suzuki and is headquartered…
Holland & Barrett, a leading health and wellness retailer, has acquired women’s health startup Parla for an undisclosed amount. The company shared on LinkedIn: To achieve our vision and be the trusted partner to millions, helping people achieve their personal health and wellness goals, we’re committed to extending our support beyond retail, offering wellness solutions and services. We recently acquired Parla the first ever-virtual support…
London-based Apricity, the company known for its virtual fertility clinics, has acquired Woom, a women’s health app offering period tracking and community support for those trying to conceive. Woom was founded in 2015 by Clelia Morales and Laurence Fontinoy in Spain and has created a robust AI engine that offers a personalized period tracker and manages a community of 1.8 million registered…
Adyn is a precision medicine company that combines hormone measurements with genetic analysis to generate medically actionable insights for every individual. This week the company is launching its first product, The Birth Control Test, that is designed to prevent birth control side effects. While some side effects—like weight gain and acne—are a nuisance, others—like blood clots and depression—can be life-threatening. With approximately…
Fairtility, the company behind CHLOE EQ, an AI platform designed to improve IVF ourcomes, has raised $15M in Series A funding round, bringing total funding to $18.5M to date. The round was led by Gurnet Point Capital with participation from Nacre Capital and additional investors. Lacking objective and consistent methods for consolidating and interpreting end-to-end data from the embryology lab, IVF yields suboptimal…
A study led by researchers at Alife Health, a fertility technology company building artificial intelligence (AI) tools designed to improve in-vitro fertilization (IVF) outcomes, found that an interpretable machine learning model can help doctors optimize ovulation trigger injection timing to improve patient outcomes for a significant number of patients. When undergoing IVF, patients are prescribed fertility medications to stimulate the ovaries to…
Male fertility startup Legacy has raised $25M in Series B funding led by Bain Capital Ventures. Other participants in the round include existing investors FirstMark Capital, Section 32 and TQ Ventures, as well as new investor Valor Equity Partners. This financing brings the company’s total funding to $45M. Legacy was founded in 2018 by Khaled Kteily with the goal to demystify male…
